EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for NVNO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -5.365
March 31, 2026 -5.885
December 31, 2025 -5.909
September 30, 2025 -7.882
June 30, 2025 -11.51
March 31, 2025 -0.2213
December 31, 2024 -12.43
September 30, 2024 -0.3512
June 30, 2024 -0.3085
March 31, 2024 -0.3109
December 31, 2023 -0.4242
September 30, 2023 -0.4453
June 30, 2023 -0.5764
March 31, 2023 -0.5691
December 31, 2022 -0.6524
September 30, 2022 -0.543
June 30, 2022 -0.6289
March 31, 2022 -0.4747
December 31, 2021 -0.9491
Date Value
September 30, 2021 -0.2603
June 30, 2021 -0.2794
March 31, 2021 -0.483
December 31, 2020 -2.845
September 30, 2020 -1.382
June 30, 2020 -1.895
March 31, 2020 -1.573
December 31, 2019 -3.194
September 30, 2019 -2.532
June 30, 2019 -3.279
March 31, 2019 -3.207
December 31, 2018 -3.800
September 30, 2018 -3.132
June 30, 2018 -26.50
March 31, 2018 -10.59
December 31, 2017 -7.066
September 30, 2017 -5.152
December 31, 2016 -124.64

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5324
AngioDynamics, Inc. -0.2735
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832
Baxter International, Inc. 0.2432

EPS Diluted (Quarterly) Related Metrics